Found: 251
Select item for more details and to access through your institution.
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 3, p. 345, doi. 10.3350/cmh.2023.0553
- By:
- Publication type:
- Article
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 627, doi. 10.1111/hepr.14021
- By:
- Publication type:
- Article
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma.
- Published in:
- Yonsei Medical Journal, 2024, v. 65, n. 7, p. 371, doi. 10.3349/ymj.2023.0263
- By:
- Publication type:
- Article
Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 6, p. 1155, doi. 10.1111/jgh.16506
- By:
- Publication type:
- Article
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.
- Published in:
- Gut & Liver, 2024, v. 18, n. 3, p. 509, doi. 10.5009/gnl230238
- By:
- Publication type:
- Article
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 8, p. 973, doi. 10.1111/apt.17909
- By:
- Publication type:
- Article
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
- Published in:
- Gut & Liver, 2024, v. 18, n. 2, p. 294, doi. 10.5009/gnl220409
- By:
- Publication type:
- Article
Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2023.1306134
- By:
- Publication type:
- Article
Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 108, doi. 10.1093/infdis/jiad273
- By:
- Publication type:
- Article
Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01355-2
- By:
- Publication type:
- Article
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 920, doi. 10.1111/apt.17699
- By:
- Publication type:
- Article
Utility of fusion imaging for the evaluation of ultrasound quality in hepatocellular carcinoma surveillance.
- Published in:
- Ultrasonography, 2023, v. 42, n. 4, p. 580, doi. 10.14366/usg.23106
- By:
- Publication type:
- Article
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1598, doi. 10.1111/jgh.16261
- By:
- Publication type:
- Article
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1372, doi. 10.1111/jgh.16210
- By:
- Publication type:
- Article
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1813, doi. 10.1111/liv.15597
- By:
- Publication type:
- Article
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 99, doi. 10.1111/apt.17532
- By:
- Publication type:
- Article
Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes.
- Published in:
- Gut & Liver, 2023, v. 17, n. 4, p. 610, doi. 10.5009/gnl220400
- By:
- Publication type:
- Article
Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2936, doi. 10.3390/cancers15112936
- By:
- Publication type:
- Article
The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 5, p. 716, doi. 10.1111/jgh.16132
- By:
- Publication type:
- Article
Global burden of primary liver cancer and its asso- ciation with underlying aetiologies, sociodemo- graphic status, and sex differences from 1990– 2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 433, doi. 10.3350/cmh.2022.0316
- By:
- Publication type:
- Article
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 319, doi. 10.1111/jvh.13796
- By:
- Publication type:
- Article
Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease.
- Published in:
- Gut & Liver, 2023, v. 17, n. 2, p. 299, doi. 10.5009/gnl220032
- By:
- Publication type:
- Article
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 608, doi. 10.1111/liv.15508
- By:
- Publication type:
- Article
Preface.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, p. S3, doi. 10.3350/cmh.2023.0014
- By:
- Publication type:
- Article
Special thanks.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, p. S4, doi. 10.3350/cmh.2023.0010
- By:
- Publication type:
- Article
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, p. S136, doi. 10.3350/cmh.2022.0436
- By:
- Publication type:
- Article
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B.
- Published in:
- Journal of Digestive Diseases, 2023, v. 24, n. 2, p. 113, doi. 10.1111/1751-2980.13172
- By:
- Publication type:
- Article
Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adults.
- Published in:
- Clinical Hypertension, 2023, v. 29, n. 1, p. 1, doi. 10.1186/s40885-022-00227-0
- By:
- Publication type:
- Article
Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma.
- Published in:
- Frontiers in Endocrinology, 2023, v. 13, p. 1, doi. 10.3389/fendo.2022.1057769
- By:
- Publication type:
- Article
Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 1, p. 667, doi. 10.3390/ijerph20010667
- By:
- Publication type:
- Article
Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease.
- Published in:
- Abdominal Radiology, 2022, v. 47, n. 11, p. 3733, doi. 10.1007/s00261-022-03618-x
- By:
- Publication type:
- Article
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2408, doi. 10.1111/liv.15388
- By:
- Publication type:
- Article
MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients.
- Published in:
- Drug Design, Development & Therapy, 2022, v. 16, p. 3263, doi. 10.2147/DDDT.S376821
- By:
- Publication type:
- Article
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease.
- Published in:
- Gut & Liver, 2022, v. 16, n. 5, p. 786, doi. 10.5009/gnl210290
- By:
- Publication type:
- Article
The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta‐analyses of randomized controlled trials.
- Published in:
- Obesity Reviews, 2022, v. 23, n. 9, p. 1, doi. 10.1111/obr.13464
- By:
- Publication type:
- Article
Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 1902, doi. 10.1111/liv.15282
- By:
- Publication type:
- Article
Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02428-1
- By:
- Publication type:
- Article
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 425, doi. 10.3350/cmh.2022.0186
- By:
- Publication type:
- Article
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 7, p. 3412, doi. 10.1007/s10620-021-07157-1
- By:
- Publication type:
- Article
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2396, doi. 10.3390/cancers14102396
- By:
- Publication type:
- Article
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 576, doi. 10.1002/cpdd.1045
- By:
- Publication type:
- Article
Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B.
- Published in:
- Liver International, 2022, v. 42, n. 5, p. 1017, doi. 10.1111/liv.15208
- By:
- Publication type:
- Article
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 4, p. 289, doi. 10.1111/jvh.13656
- By:
- Publication type:
- Article
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease.
- Published in:
- Diabetologia, 2022, v. 65, n. 3, p. 518, doi. 10.1007/s00125-021-05627-9
- By:
- Publication type:
- Article
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
- Published in:
- Gut & Liver, 2022, v. 16, n. 2, p. 290, doi. 10.5009/gnl210084
- By:
- Publication type:
- Article
Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 3, p. 428, doi. 10.1111/jgh.15727
- By:
- Publication type:
- Article
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 385, doi. 10.3390/cancers14020385
- By:
- Publication type:
- Article